Compare Stocks

5 / 10
Try these comparisons:

Stock Comparison

CCRN vs AMN vs TBI vs HCSG vs KELYA

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
CCRN
Cross Country Healthcare, Inc.

Medical - Care Facilities

HealthcareNASDAQ • US
Market Cap$423M
5Y Perf.+115.7%
AMN
AMN Healthcare Services, Inc.

Medical - Care Facilities

HealthcareNYSE • US
Market Cap$869M
5Y Perf.-49.3%
TBI
TrueBlue, Inc.

Staffing & Employment Services

IndustrialsNYSE • US
Market Cap$182M
5Y Perf.-61.1%
HCSG
Healthcare Services Group, Inc.

Medical - Care Facilities

HealthcareNASDAQ • US
Market Cap$1.60B
5Y Perf.-6.7%
KELYA
Kelly Services, Inc.

Staffing & Employment Services

IndustrialsNASDAQ • US
Market Cap$349M
5Y Perf.-35.3%

CCRN vs AMN vs TBI vs HCSG vs KELYA — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
CCRN logoCCRN
AMN logoAMN
TBI logoTBI
HCSG logoHCSG
KELYA logoKELYA
IndustryMedical - Care FacilitiesMedical - Care FacilitiesStaffing & Employment ServicesMedical - Care FacilitiesStaffing & Employment Services
Market Cap$423M$869M$182M$1.60B$349M
Revenue (TTM)$761M$3.42B$1.25B$1.84B$3.09B
Net Income (TTM)$-99M$-32M$-53M$59M$-266M
Gross Margin18.2%25.5%28.4%13.3%26.3%
Operating Margin-0.9%0.3%-2.6%3.0%-2.8%
Forward P/E133.8x11.0x20.8x11.0x
Total Debt$2M$803M$171M$25M$159M
Cash & Equiv.$109M$34M$25M$161M$33M

CCRN vs AMN vs TBI vs HCSG vs KELYALong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

CCRN
AMN
TBI
HCSG
KELYA
StockMay 20May 26Return
Cross Country Healt… (CCRN)100215.7+115.7%
AMN Healthcare Serv… (AMN)10050.7-49.3%
TrueBlue, Inc. (TBI)10038.9-61.1%
Healthcare Services… (HCSG)10093.3-6.7%
Kelly Services, Inc. (KELYA)10064.7-35.3%

Price return only. Dividends and distributions are not included.

Quick Verdict: CCRN vs AMN vs TBI vs HCSG vs KELYA

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: HCSG leads in 4 of 7 categories (5-stock set), making it the strongest pick for growth and revenue expansion and profitability and margin quality. Kelly Services, Inc. is the stronger pick specifically for valuation and capital efficiency and dividend income and shareholder returns. CCRN also leads in specific categories worth noting. This set spans 2 sectors — these stocks serve different portfolio roles, not just different price points.
CCRN
Cross Country Healthcare, Inc.
The Long-Run Compounder

CCRN ranks third and is worth considering specifically for long-term compounding and sleep-well-at-night.

  • -10.5% 10Y total return vs HCSG's -26.8%
  • Lower volatility, beta 0.78, Low D/E 0.7%, current ratio 3.78x
  • Beta 0.78, current ratio 3.78x
  • Beta 0.78 vs TBI's 1.13, lower leverage
Best for: long-term compounding and sleep-well-at-night
AMN
AMN Healthcare Services, Inc.
The Value Angle

AMN lags the leaders in this set but could rank higher in a more targeted comparison.

Best for: healthcare exposure
TBI
TrueBlue, Inc.
The Industrials Pick

Among these 5 stocks, TBI doesn't own a clear edge in any measured category.

Best for: industrials exposure
HCSG
Healthcare Services Group, Inc.
The Growth Play

HCSG carries the broadest edge in this set and is the clearest fit for growth exposure.

  • Rev growth 7.1%, EPS growth 52.8%, 3Y rev CAGR 2.8%
  • 7.1% revenue growth vs CCRN's -21.6%
  • 3.2% margin vs CCRN's -13.0%
  • +55.8% vs KELYA's -12.2%
Best for: growth exposure
KELYA
Kelly Services, Inc.
The Income Pick

KELYA is the #2 pick in this set and the best alternative if income & stability is your priority.

  • Dividend streak 5 yrs, beta 1.01, yield 3.2%
  • Lower P/E (11.0x vs 20.8x)
  • 3.2% yield; 5-year raise streak; the other 4 pay no meaningful dividend
Best for: income & stability
See the full category breakdown
CategoryWinnerWhy
GrowthHCSG logoHCSG7.1% revenue growth vs CCRN's -21.6%
ValueKELYA logoKELYALower P/E (11.0x vs 20.8x)
Quality / MarginsHCSG logoHCSG3.2% margin vs CCRN's -13.0%
Stability / SafetyCCRN logoCCRNBeta 0.78 vs TBI's 1.13, lower leverage
DividendsKELYA logoKELYA3.2% yield; 5-year raise streak; the other 4 pay no meaningful dividend
Momentum (1Y)HCSG logoHCSG+55.8% vs KELYA's -12.2%
Efficiency (ROA)HCSG logoHCSG7.3% ROA vs CCRN's -19.8%, ROIC 9.0% vs -0.9%

CCRN vs AMN vs TBI vs HCSG vs KELYA — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

CCRNCross Country Healthcare, Inc.
FY 2025
Other Services
100.0%$30M
AMNAMN Healthcare Services, Inc.
FY 2025
Locum Tenens Staffing
92.4%$565M
Permanent Placement
7.6%$47M
TBITrueBlue, Inc.
FY 2025
PeopleReady
54.7%$884M
PeopleManagement
33.7%$544M
PeopleScout
11.6%$188M
HCSGHealthcare Services Group, Inc.
FY 2025
Dietary Services
55.1%$1.0B
Environmental Services
44.9%$825M
KELYAKelly Services, Inc.
FY 2025
Science, Engineering & Technology
55.1%$1.2B
Education
44.9%$1.0B

CCRN vs AMN vs TBI vs HCSG vs KELYA — Financial Metrics

Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLHCSGLAGGINGTBI

Income & Cash Flow (Last 12 Months)

AMN leads this category, winning 3 of 6 comparable metrics.

AMN is the larger business by revenue, generating $3.4B annually — 4.5x CCRN's $761M. HCSG is the more profitable business, keeping 3.2% of every revenue dollar as net income compared to CCRN's -13.0%. On growth, AMN holds the edge at +99.9% YoY revenue growth, suggesting stronger near-term business momentum.

MetricCCRN logoCCRNCross Country Hea…AMN logoAMNAMN Healthcare Se…TBI logoTBITrueBlue, Inc.HCSG logoHCSGHealthcare Servic…KELYA logoKELYAKelly Services, I…
RevenueTrailing 12 months$761M$3.4B$1.2B$1.8B$3.1B
EBITDAEarnings before interest/tax$9M$127M-$10M$72M-$54M
Net IncomeAfter-tax profit-$99M-$32M-$53M$59M-$266M
Free Cash FlowCash after capex$41M$714M-$60M$139M$66M
Gross MarginGross profit ÷ Revenue+18.2%+25.5%+28.4%+13.3%+26.3%
Operating MarginEBIT ÷ Revenue-0.9%+0.3%-2.6%+3.0%-2.8%
Net MarginNet income ÷ Revenue-13.0%-0.9%-4.3%+3.2%-8.6%
FCF MarginFCF ÷ Revenue+5.4%+20.9%-4.8%+7.6%+2.1%
Rev. Growth (YoY)Latest quarter vs prior year-100.0%+99.9%-100.0%+6.6%-100.0%
EPS Growth (YoY)Latest quarter vs prior year-6.0%+56.8%-37.5%+175.0%-2.1%
AMN leads this category, winning 3 of 6 comparable metrics.

Valuation Metrics

KELYA leads this category, winning 4 of 6 comparable metrics.

On an enterprise value basis, AMN's 8.6x EV/EBITDA is more attractive than TBI's 160.0x.

MetricCCRN logoCCRNCross Country Hea…AMN logoAMNAMN Healthcare Se…TBI logoTBITrueBlue, Inc.HCSG logoHCSGHealthcare Servic…KELYA logoKELYAKelly Services, I…
Market CapShares × price$423M$869M$182M$1.6B$349M
Enterprise ValueMkt cap + debt − cash$317M$1.6B$329M$1.5B$475M
Trailing P/EPrice ÷ TTM EPS-4.47x-9.06x-3.73x27.54x-1.34x
Forward P/EPrice ÷ next-FY EPS est.133.84x11.05x20.83x10.96x
PEG RatioP/E ÷ EPS growth rate
EV / EBITDAEnterprise value multiple23.75x8.63x160.03x22.38x
Price / SalesMarket cap ÷ Revenue0.40x0.32x0.11x0.87x0.08x
Price / BookPrice ÷ Book value/share1.31x1.35x0.65x3.19x0.35x
Price / FCFMarket cap ÷ FCF10.55x3.72x11.49x3.06x
KELYA leads this category, winning 4 of 6 comparable metrics.

Profitability & Efficiency

HCSG leads this category, winning 7 of 9 comparable metrics.

HCSG delivers a 11.8% return on equity — every $100 of shareholder capital generates $12 in annual profit, vs $-27 for CCRN. CCRN carries lower financial leverage with a 0.01x debt-to-equity ratio, signaling a more conservative balance sheet compared to AMN's 1.25x. On the Piotroski fundamental quality scale (0–9), HCSG scores 7/9 vs TBI's 4/9, reflecting strong financial health.

MetricCCRN logoCCRNCross Country Hea…AMN logoAMNAMN Healthcare Se…TBI logoTBITrueBlue, Inc.HCSG logoHCSGHealthcare Servic…KELYA logoKELYAKelly Services, I…
ROE (TTM)Return on equity-27.1%-5.0%-18.7%+11.8%-24.6%
ROA (TTM)Return on assets-19.8%-1.4%-8.1%+7.3%-11.3%
ROICReturn on invested capital-0.9%+1.6%-5.2%+9.0%-4.0%
ROCEReturn on capital employed-0.8%+2.0%-5.3%+7.7%-4.3%
Piotroski ScoreFundamental quality 0–965475
Debt / EquityFinancial leverage0.01x1.25x0.62x0.05x0.16x
Net DebtTotal debt minus cash-$106M$769M$146M-$136M$126M
Cash & Equiv.Liquid assets$109M$34M$25M$161M$33M
Total DebtShort + long-term debt$2M$803M$171M$25M$159M
Interest CoverageEBIT ÷ Interest expense-1.39x-1.70x-46.19x33.02x-12.07x
HCSG leads this category, winning 7 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

HCSG leads this category, winning 4 of 6 comparable metrics.

A $10,000 investment in HCSG five years ago would be worth $7,888 today (with dividends reinvested), compared to $2,130 for TBI. Over the past 12 months, HCSG leads with a +55.8% total return vs KELYA's -12.2%. The 3-year compound annual growth rate (CAGR) favors HCSG at 14.1% vs AMN's -37.1% — a key indicator of consistent wealth creation.

MetricCCRN logoCCRNCross Country Hea…AMN logoAMNAMN Healthcare Se…TBI logoTBITrueBlue, Inc.HCSG logoHCSGHealthcare Servic…KELYA logoKELYAKelly Services, I…
YTD ReturnYear-to-date+62.4%+48.7%+36.6%+28.6%+13.1%
1-Year ReturnPast 12 months-5.4%+14.6%+51.0%+55.8%-12.2%
3-Year ReturnCumulative with dividends-44.3%-75.1%-60.2%+48.6%-34.2%
5-Year ReturnCumulative with dividends-22.5%-75.1%-78.7%-21.1%-58.3%
10-Year ReturnCumulative with dividends-10.5%-41.5%-68.4%-26.8%-33.0%
CAGR (3Y)Annualised 3-year return-17.7%-37.1%-26.4%+14.1%-13.0%
HCSG leads this category, winning 4 of 6 comparable metrics.

Risk & Volatility

Evenly matched — CCRN and AMN each lead in 1 of 2 comparable metrics.

CCRN is the less volatile stock with a 0.78 beta — it tends to amplify market swings less than TBI's 1.13 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. AMN currently trades 94.7% from its 52-week high vs KELYA's 64.9% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricCCRN logoCCRNCross Country Hea…AMN logoAMNAMN Healthcare Se…TBI logoTBITrueBlue, Inc.HCSG logoHCSGHealthcare Servic…KELYA logoKELYAKelly Services, I…
Beta (5Y)Sensitivity to S&P 5000.78x1.08x1.13x1.12x1.01x
52-Week HighHighest price in past year$14.99$23.74$7.78$24.39$14.94
52-Week LowLowest price in past year$7.43$14.87$3.18$12.66$7.98
% of 52W HighCurrent price vs 52-week peak+87.3%+94.7%+77.2%+91.5%+64.9%
RSI (14)Momentum oscillator 0–10053.157.283.261.863.7
Avg Volume (50D)Average daily shares traded552K849K386K676K361K
Evenly matched — CCRN and AMN each lead in 1 of 2 comparable metrics.

Analyst Outlook

HCSG leads this category, winning 1 of 1 comparable metric.

Analyst consensus: CCRN as "Hold", AMN as "Buy", TBI as "Buy", HCSG as "Hold", KELYA as "Buy". Consensus price targets imply 54.6% upside for KELYA (target: $15) vs -18.9% for CCRN (target: $11). KELYA is the only dividend payer here at 3.23% yield — a key consideration for income-focused portfolios.

MetricCCRN logoCCRNCross Country Hea…AMN logoAMNAMN Healthcare Se…TBI logoTBITrueBlue, Inc.HCSG logoHCSGHealthcare Servic…KELYA logoKELYAKelly Services, I…
Analyst RatingConsensus buy/hold/sellHoldBuyBuyHoldBuy
Price TargetConsensus 12-month target$10.61$22.50$5.75$24.50$15.00
# AnalystsCovering analysts141710155
Dividend YieldAnnual dividend ÷ price+3.2%
Dividend StreakConsecutive years of raises10205
Dividend / ShareAnnual DPS$0.31
Buyback YieldShare repurchases ÷ mkt cap+1.6%+0.2%+0.6%+3.9%+3.5%
HCSG leads this category, winning 1 of 1 comparable metric.
Key Takeaway

HCSG leads in 3 of 6 categories (Profitability & Efficiency, Total Returns). AMN leads in 1 (Income & Cash Flow). 1 tied.

Best OverallHealthcare Services Group, … (HCSG)Leads 3 of 6 categories
Loading custom metrics...

CCRN vs AMN vs TBI vs HCSG vs KELYA: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is CCRN or AMN or TBI or HCSG or KELYA a better buy right now?

For growth investors, Healthcare Services Group, Inc.

(HCSG) is the stronger pick with 7. 1% revenue growth year-over-year, versus -21. 6% for Cross Country Healthcare, Inc. (CCRN). Healthcare Services Group, Inc. (HCSG) offers the better valuation at 27. 5x trailing P/E (20. 8x forward), making it the more compelling value choice. Analysts rate AMN Healthcare Services, Inc. (AMN) a "Buy" — based on 17 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — CCRN or AMN or TBI or HCSG or KELYA?

On forward P/E, Kelly Services, Inc.

is actually cheaper at 11. 0x — notably different from the trailing picture, reflecting expected earnings growth.

03

Which is the better long-term investment — CCRN or AMN or TBI or HCSG or KELYA?

Over the past 5 years, Healthcare Services Group, Inc.

(HCSG) delivered a total return of -21. 1%, compared to -78. 7% for TrueBlue, Inc. (TBI). Over 10 years, the gap is even starker: CCRN returned -10. 5% versus TBI's -68. 4%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — CCRN or AMN or TBI or HCSG or KELYA?

By beta (market sensitivity over 5 years), Cross Country Healthcare, Inc.

(CCRN) is the lower-risk stock at 0. 78β versus TrueBlue, Inc. 's 1. 13β — meaning TBI is approximately 46% more volatile than CCRN relative to the S&P 500. On balance sheet safety, Cross Country Healthcare, Inc. (CCRN) carries a lower debt/equity ratio of 1% versus 125% for AMN Healthcare Services, Inc. — giving it more financial flexibility in a downturn.

05

Which is growing faster — CCRN or AMN or TBI or HCSG or KELYA?

By revenue growth (latest reported year), Healthcare Services Group, Inc.

(HCSG) is pulling ahead at 7. 1% versus -21. 6% for Cross Country Healthcare, Inc. (CCRN). On earnings-per-share growth, the picture is similar: TrueBlue, Inc. grew EPS 61. 4% year-over-year, compared to -427. 4% for Kelly Services, Inc.. Over a 3-year CAGR, HCSG leads at 2. 8% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — CCRN or AMN or TBI or HCSG or KELYA?

Healthcare Services Group, Inc.

(HCSG) is the more profitable company, earning 3. 2% net margin versus -9. 0% for Cross Country Healthcare, Inc. — meaning it keeps 3. 2% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: HCSG leads at 2. 6% versus -1. 7% for TBI. At the gross margin level — before operating expenses — AMN leads at 22. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is CCRN or AMN or TBI or HCSG or KELYA more undervalued right now?

On forward earnings alone, Kelly Services, Inc.

(KELYA) trades at 11. 0x forward P/E versus 133. 8x for Cross Country Healthcare, Inc. — 122. 9x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for KELYA: 54. 6% to $15. 00.

08

Which pays a better dividend — CCRN or AMN or TBI or HCSG or KELYA?

In this comparison, KELYA (3.

2% yield) pays a dividend. CCRN, AMN, TBI, HCSG do not pay a meaningful dividend and should not be held primarily for income.

09

Is CCRN or AMN or TBI or HCSG or KELYA better for a retirement portfolio?

For long-horizon retirement investors, Kelly Services, Inc.

(KELYA) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1. 01), 3. 2% yield). Both have compounded well over 10 years (KELYA: -33. 0%, TBI: -68. 4%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between CCRN and AMN and TBI and HCSG and KELYA?

These companies operate in different sectors (CCRN (Healthcare) and AMN (Healthcare) and TBI (Industrials) and HCSG (Healthcare) and KELYA (Industrials)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: CCRN is a small-cap quality compounder stock; AMN is a small-cap quality compounder stock; TBI is a small-cap quality compounder stock; HCSG is a small-cap quality compounder stock; KELYA is a small-cap income-oriented stock. KELYA pays a dividend while CCRN, AMN, TBI, HCSG do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.

Stocks Like

CCRN

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
Run This Screen
Stocks Like

AMN

High-Growth Disruptor

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 49%
  • Gross Margin > 15%
Run This Screen
Stocks Like

TBI

Quality Business

  • Sector: Industrials
  • Market Cap > $100B
  • Gross Margin > 17%
Run This Screen
Stocks Like

HCSG

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 5%
Run This Screen
Stocks Like

KELYA

Income & Dividend Stock

  • Sector: Industrials
  • Market Cap > $100B
  • Gross Margin > 15%
  • Dividend Yield > 1.2%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform CCRN and AMN and TBI and HCSG and KELYA on the metrics below

Revenue Growth>
%
(CCRN: -100.0% · AMN: 99.9%)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.